[updated] IQuity, SafeStamp, Frontier Diagnostics, Neurodyne pitch to local VCs.
CEO Winkelspecht is working with HC customers on proof of concept technologies.
Breast cancer target, regulatory progress and further capital raise action likely.
Think it's 'Much Ado' about nothing? Sorry, the jury's not really 'out' regarding the importance of original content
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: